We found that these mice developed fast-growing breast tumors containing hundreds of somatically mutated, amplified or deleted genes, and many of these altered genes are also mutated, amplified or deleted in human breast cancers with both deficient P53 and activated PTEN-PI3K-AKT pathway. This evidence concerns the gene TP53 and breast cancer.